Show simple item record

dc.contributor.authorPiñero, Federico.
dc.contributor.authorMendizabal, Manuel.
dc.contributor.authorSilva, Marcelo.
dc.contributor.authorEt al.
dc.date.accessioned2023-07-05T14:18:42Z
dc.date.available2023-07-05T14:18:42Z
dc.date.issued2021-02
dc.identifier.citationJ Viral Hepat . 2021 Feb;28(2):446-447.es
dc.identifier.issn1365-2893
dc.identifier.urihttps://riu.austral.edu.ar/handle/123456789/2213
dc.descriptionDisponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jvh.13433es
dc.description.abstractComment J Viral Hepat . 2021 Feb;28(2):446-447. doi: 10.1111/jvh.13433. Epub 2020 Nov 18. Direct-acting antiviral treatment failure in genotype 2 hepatitis C chronic infection Ezequiel Ridruejo 1 2 3, Federico Piñero 2 3, Manuel Mendizabal 2 3, Marcelo Silva 2 3; Latin American Liver Research Educational, Awareness Network (LALREAN) Affiliations expand PMID: 33147362 DOI: 10.1111/jvh.13433es
dc.language.isoenes
dc.publisherWileyes
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectHepatitis C virus.es
dc.subjectChronic infection.es
dc.subjectAntiviral treatment failure.es
dc.titleDirect-acting antiviral treatment failure in genotype 2 hepatitis C chronic infectiones
dc.typeArticlees


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional